evidencegaps
Primary study · included by 1 review

Comparison between the Radiographic and Clinical Rates of Success for TheraCal and MTA in Primary Tooth Pulpotomy within a 12-Month Follow-Up: A Split-Mouth Clinical Trial.

Hassanpour 2023 · Hassanpour Sedigheh, Aminabadi Naser Asl, Rahbar Mahdi, et al. · BioMed research international · 2023

Included by

Resin-Modified Calcium Silicate-Based Materials Versus Conventional Formulations in Primary Teeth: A Systematic Review and Meta-Analysis of Clinical and Radiographic Outcomes of Vital Pulp Therapy Procedures in Pediatric Dentistry.
Non-Cochrane · intervention · 2026 · cited as Hassanpour 2023 · Table 2; Reference 39
Outcome this study informsPooled effectEvidenceCertainty
Overall clinical and radiographic success
TheraCal LC (resin-modified calcium silicate) in vital pulp therapy (ipc, dpc, pulpotomy) vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · <360 days
RR 0.99 [0.96, 1.02]7 studies · 400 participantsLow
Overall clinical and radiographic success
TheraCal LC (resin-modified calcium silicate) in vital pulp therapy (ipc, dpc, pulpotomy) vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · >=360 days
RR 0.95 [0.89, 1.01]5 studies · 355 participantsLow
Overall clinical and radiographic success
TheraCal LC (resin-modified calcium silicate) for pulpotomy vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · >=360 days
RR 0.95 [0.85, 1.06]2 studies · 124 participantsLow

1 including review in total.